Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells ; volume:130 ; number:8 ; day:4 ; month:4 ; year:2024 ; pages:1414 ; date:5.2024
British journal of cancer ; 130, Heft 8 (4.4.2024), 1414, 5.2024
- Urheber
-
Rio-Vilariño, Anxo
Cenigaonandia-Campillo, Aiora
García-Bautista, Ana
Mateos-Gómez, Pedro A.
Schlaepfer, Marina I.
Puerto-Nevado, Laura del
Aguilera, Oscar
García-García, Laura
Galeano, Carlos
Miguel, Irene de
Serrano-López, Juana
Baños, Natalia
Fernández-Aceñero, María Jesús
Lacal, Juan Carlos
Medico, Enzo
García-Foncillas, Jesús
Cebrián, Arancha
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-024-02667-x
- URN
-
urn:nbn:de:101:1-2406252121071.663148890188
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rio-Vilariño, Anxo
- Cenigaonandia-Campillo, Aiora
- García-Bautista, Ana
- Mateos-Gómez, Pedro A.
- Schlaepfer, Marina I.
- Puerto-Nevado, Laura del
- Aguilera, Oscar
- García-García, Laura
- Galeano, Carlos
- Miguel, Irene de
- Serrano-López, Juana
- Baños, Natalia
- Fernández-Aceñero, María Jesús
- Lacal, Juan Carlos
- Medico, Enzo
- García-Foncillas, Jesús
- Cebrián, Arancha
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Ghrelin as a Promising Therapeutic Option for Cancer Cachexia
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy
Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance
Cell-Free Protein Synthesis: A Promising Option for Future Drug Development
Requirement for YAP1 signaling in myxoid liposarcoma
YAP1-fusions in pediatric NF2-wildtype meningioma
The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Ghrelin as a Promising Therapeutic Option for Cancer Cachexia
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy
Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance
Cell-Free Protein Synthesis: A Promising Option for Future Drug Development
Requirement for YAP1 signaling in myxoid liposarcoma
YAP1-fusions in pediatric NF2-wildtype meningioma
The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Ghrelin as a Promising Therapeutic Option for Cancer Cachexia
Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy
Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance
Cell-Free Protein Synthesis: A Promising Option for Future Drug Development
Requirement for YAP1 signaling in myxoid liposarcoma
YAP1-fusions in pediatric NF2-wildtype meningioma